Prosight Management, LP Pliant Therapeutics, Inc. Transaction History
Prosight Management, LP
- $369 Million
- Q2 2025
A detailed history of Prosight Management, LP transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Prosight Management, LP holds 837,400 shares of PLRX stock, worth $1.54 Million. This represents 0.26% of its overall portfolio holdings.
Number of Shares
837,400
Previous 334,263
150.52%
Holding current value
$1.54 Million
Previous $451,000
115.3%
% of portfolio
0.26%
Previous 0.16%
Shares
2 transactions
Others Institutions Holding PLRX
# of Institutions
125Shares Held
57.7MCall Options Held
245KPut Options Held
86.7K-
Tang Capital Management LLC San Diego, CA6MShares$11 Million0.42% of portfolio
-
Black Rock Inc. New York, NY4.97MShares$9.15 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.95MShares$7.26 Million0.16% of portfolio
-
Morgan Stanley New York, NY3.75MShares$6.91 Million0.0% of portfolio
-
Chi Advisors LLC New York, NY3.01MShares$5.55 Million25.76% of portfolio
About PLIANT THERAPEUTICS, INC.
- Ticker PLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,682,000
- Market Cap $89.6M
- Description
- Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...